Although IgA immune deposits were prevalent, lack of reporting of immunofluorescence findings in most papers hinders a thorough analysis of above-mentioned cases and calls for further studies, as the very nature of immune deposits in the non-COVID-19/COVID-19-vaccine-associated setting is still debated (5). This evidence concerns the gene CD79A and COVID-19.